| Calcium–siRNA nanocomplexes: What reversibility is all about E Ruvinov, O Kryukov, E Forti, E Korin, M Goldstein, S Cohen Journal of controlled release 203, 150-160, 2015 | 41 | 2015 |
| Mechanisms of cellular uptake and endosomal escape of calcium-siRNA nanocomplexes M Goldshtein, E Forti, E Ruvinov, S Cohen International journal of pharmaceutics 515 (1-2), 46-56, 2016 | 36 | 2016 |
| Co-assembled Ca2+ Alginate-Sulfate Nanoparticles for Intracellular Plasmid DNA Delivery M Goldshtein, S Shamir, E Vinogradov, A Monsonego, S Cohen Molecular Therapy-Nucleic Acids 16, 378-390, 2019 | 27 | 2019 |
| A bridge to silencing: Co-assembling anionic nanoparticles of siRNA and hyaluronan sulfate via calcium ion bridges E Forti, O Kryukov, E Elovic, M Goldshtein, E Korin, G Margolis, S Felder, ... Journal of Controlled Release 232, 215-227, 2016 | 17 | 2016 |
| Defining the timeline of periostin upregulation in cardiac fibrosis following acute myocardial infarction in mice H Gil, M Goldshtein, S Etzion, S Elyagon, U Hadad, Y Etzion, S Cohen Scientific Reports 12 (1), 21863, 2022 | 16 | 2022 |
| Transcription factor binding in embryonic stem cells is constrained by DNA sequence repeat symmetry M Goldshtein, M Mellul, G Deutch, M Imashimizu, K Takeuchi, E Meshorer, ... Biophysical Journal, 2020 | 9 | 2020 |
| Specificity-determining DNA triplet code for positioning of human preinitiation complex M Goldshtein, DB Lukatsky Biophysical journal 112 (10), 2047-2050, 2017 | 8 | 2017 |
| Nitric oxide is a powerful anti-coronavirus-inhaled agent that acts within hours M Goldshtein, O Lerner, R Kalaora, S Yarkoni, E Dekel, H Confino, ... Chest 158 (4), A2446, 2020 | 2 | 2020 |
| Intratumoral Administration of High-Concentration Nitric Oxide and Anti-mPD-1 Treatment Improves Tumor Regression Rates and Survival in CT26 Tumor-Bearing Mice H Confino, Y Sela, Y Epshtein, L Malka, M Goldshtein, S Chaisson, S Lisi, ... Cells 12 (20), 2439, 2023 | 1 | 2023 |
| Gaseous nitric oxide tumor ablation induces an anti-tumor abscopal effect H Confino, FM Dirbas, M Goldshtein, S Yarkoni, R Kalaora, M Hatan, ... Cancer Cell International 22 (1), 405, 2022 | 1 | 2022 |
| MO01. 15 Nitric Oxide Lung Cancer Active Vaccination H Confino, S Yarkoni, M Goldshtein, E Dekel, O Lerner, S Puyesky, S Lisi, ... Journal of Thoracic Oncology 16 (1), S22, 2021 | 1 | 2021 |
| 724 Intratumoral administration of low volume ultra-high concentration nitric oxide (UNO201) and immune checkpoint inhibitor in CT26 tumor-bearing mice H Confino, Y Sela, Y Epshtein, T Bar-Dor, M Goldshtein, S Chaisson, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |
| Methods of producing tumor vaccines and uses thereof A Avniel, H Confino, M Goldshtein, SA Lisi US Patent App. 18/563,241, 2024 | | 2024 |
| Nanoparticles carrying anti-Periostin Antibody enable Specific Targeting of activated Cardiac Fibroblasts H Gil, M Goldshtein, S Etzion, S Elyagon, Y Etzion, S Cohen | | 2024 |
| System and Method for Delivery of Gas to a Tissue H Confino, SA Lisi, R Kalaora, A Avniel, M Goldshtein, S Yarkoni US Patent App. 18/368,910, 2024 | | 2024 |
| Abstract C080: Ultra-high concentration nitric oxide (UNO) enhances anti-CTLA-4 treatment activity and induces a durable anti-tumor immune response Y Sela, M Goldshtein, JM Monson, H Confino, A Avniel, MD Pegram, ... Molecular Cancer Therapeutics 22 (12_Supplement), C080-C080, 2023 | | 2023 |
| System and method for delivery of gas to a tissue H Confino, SA Lisi, R Kalaora, A Avniel, M Goldshtein, S Yarkoni US Patent 11,819,606, 2023 | | 2023 |
| Treatment of primary and/or secondary lung tumors using gaseous nitric oxide inhalation H CONFINO, M Goldshtein, S Yarkoni, O Lerner, E DEKEL, S Puyesky, ... US Patent App. 18/115,029, 2023 | | 2023 |
| Intratumoral administration of ultra high-concentration nitric oxide (UNO) is more efficacious than anti-PD1 therapy in 4T1 tumor-bearing mice Y Epshtein, M Goldshtein, S Chaisson, J Monson, M Johnson, A Avniel, ... Cancer Research 83 (7_Supplement), 6327-6327, 2023 | | 2023 |
| Short-term exposure of cancer cells to ultra-high concentrations nitric oxide induces PDL-1 upregulation Y Epshtein, M Goldshtein, S Chaisson, J Monson, M Johnson, A Avniel, ... Cancer Research 83 (7_Supplement), 6363-6363, 2023 | | 2023 |
Smadar CohenProfessor for Biotechnology Engineering, Ben Gurion University在 bgu.ac.il 的电子邮件经过验证
